Ccng2 - cyclin G2 Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 29157
Summary
Predicted to enable cyclin-dependent protein serine/threonine kinase regulator activity. Predicted to be involved in mitotic cell cycle phase transition and regulation of cyclin-dependent protein serine/threonine kinase activity. Predicted to act upstream of or within regulation of cell cycle. Predicted to be part of cyclin-dependent protein kinase holoenzyme complex. Predicted to be active in cytoplasm and nucleus. Orthologous to human CCNG2 (cyclin G2). [provided by Alliance of Genome Resources, Apr 2022]
Ccng2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001105725.2 | NP_001099195.1 | cyclin-G2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cyclin-G2 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS02131 | CCNG2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service